US Patent Issued to WUHAN BANKE BIOTECHNOLOGY on Sept. 9 for "C-based single domain antibody for neutralizing respiratory syncytial virus and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,242, issued on Sept. 9, was assigned to WUHAN BANKE BIOTECHNOLOGY Co. LTD. (Wuhan, China).

"C-based single domain antibody for neutralizing respiratory syncytial virus and application thereof" was invented by Rui Gong (Wuhan, China), Haiwei Zhang (Wuhan, China) and Ye Qin (Wuhan, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a C-based single domain antibody that neutralizes respiratory syncytial virus (RSV) and its application thereof. The C-based single domain antibody of the present disclosure is a neutralizing antibody against RSV F protein, can inhibit the viral entry into host cells, and can be used for...